Market Overview:
The global metastatic colorectal cancer surgery market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of colorectal cancer, increasing awareness about early diagnosis and treatment options for metastatic colorectal cancer, and technological advancements in the field of surgical oncology. Based on type, the global metastatic colorectal surgery market is segmented into tumor resection and portal vein embolization. Tumor resection is further sub-segmented into open surgery and laparoscopic surgery. Portal vein embolization is used for patients with liver tumors who are not candidates for surgical resection or those who have had a previous operation that has left them with an insufficient remnant liver volume. Based on application, the global metastatic colorectal surgery market is segmented into hospitals, clinics, and cancer research centers. Geographically, the global metastatic colorectal surgery market is segmented into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Metastatic Colorectal Cancer Surgery is a surgical procedure to remove tumors that have spread from the colon or rectum to other parts of the body. The importance of Metastatic Colorectal Cancer Surgery is that it may improve survival rates and quality of life for people with metastatic colorectal cancer.
Tumor Resection:
Tumor resection is surgical removal of the tumor. It can be performed by two methods: open surgery and endoscopic surgery. Endoscopic resection is a minimally invasive procedure, which involves small incisions, allowing patients to recover faster and avoid post-surgical complications.
Portal Vein Embolization:
Portal vein embolization (PVE) is a minimally invasive surgical technique used to treat patients suffering from colorectal cancer that has metastasized to the liver or beyond. This treatment method involves the injection of an embolization device through a vein into the tumor. The process helps in shrinking and blocking blood vessels that supply oxygen and nutrients to tumors, thereby reducing its size as well as growth rate.
Application Insights:
Based on application, the market is segmented into hospitals, clinics and cancer research centers. Hospitals held the largest share in 2017 owing to availability of advanced healthcare facilities at prime locations worldwide. Metastatic colorectal cancer surgery performed at hospitals offers better accessibility for patients as well as facilitates faster recovery due to highly skilled staff and advanced medical equipment available.
The clinics segment is expected to witness lucrative growth over the forecast period owing to growing awareness about early diagnosis and treatment of metastatic cancers that have spread from their original site in the colon or rectum. A rising number of clinical trials that focus on metastatic CRCs are also likely to boost market growth over the forecast period.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing prevalence of metastatic colorectal cancer, rising awareness about advanced treatment options, and availability of skilled physicians. Moreover, increasing government initiatives for raising awareness about MCC is also expected to drive growth during the forecast period. For instance, in October 2018 Cancer Research and Care Foundation (CRCF) organized “Metastatic Colorectal Cancer Awareness Month†which was an attempt to create awareness among people about different types of metastases that occur due to cancer and their symptoms so that they can get treated at an early stage thereby saving lives.
Growth Factors:
- Increasing incidence of colorectal cancer
- Growing awareness about metastatic colorectal cancer surgery
- Rising demand for minimally invasive surgeries
- Technological advancements in surgical procedures
- Increasing healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Metastatic Colorectal Cancer Surgery Market Research Report
By Type
Tumor Resection, Portal Vein Embolization
By Application
Hospitals, Clinics, Cancer Research Centers
By Companies
Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech, EMD Serono, Suzhou Zelgen Biopharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Metastatic Colorectal Cancer Surgery Market Report Segments:
The global Metastatic Colorectal Cancer Surgery market is segmented on the basis of:
Types
Tumor Resection, Portal Vein Embolization
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Cancer Research Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Roche
- Eli Lilly
- Pfizer
- Novartis
- Amgen
- Taiho Oncology
- Genentech
- EMD Serono
- Suzhou Zelgen Biopharmaceuticals
Highlights of The Metastatic Colorectal Cancer Surgery Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tumor Resection
- Portal Vein Embolization
- By Application:
- Hospitals
- Clinics
- Cancer Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Metastatic Colorectal Cancer Surgery Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Metastatic colorectal cancer surgery is a surgical procedure used to remove the cancerous tumor and any surrounding tissues. This type of surgery is often recommended if the patient has metastatic colorectal cancer, which means that the tumor has spread beyond the original site.
Some of the major companies in the metastatic colorectal cancer surgery market are Sanofi, Roche, Eli Lilly, Pfizer, Novartis, Amgen, Taiho Oncology, Genentech, EMD Serono, Suzhou Zelgen Biopharmaceuticals.
The metastatic colorectal cancer surgery market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Metastatic Colorectal Cancer Surgery Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Metastatic Colorectal Cancer Surgery Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Metastatic Colorectal Cancer Surgery Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Metastatic Colorectal Cancer Surgery Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Metastatic Colorectal Cancer Surgery Market Size & Forecast, 2020-2028
4.5.1 Metastatic Colorectal Cancer Surgery Market Size and Y-o-Y Growth
4.5.2 Metastatic Colorectal Cancer Surgery Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Tumor Resection
5.2.2 Portal Vein Embolization
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Cancer Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Metastatic Colorectal Cancer Surgery Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Metastatic Colorectal Cancer Surgery Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Tumor Resection
9.6.2 Portal Vein Embolization
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Cancer Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Tumor Resection
10.6.2 Portal Vein Embolization
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Cancer Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Tumor Resection
11.6.2 Portal Vein Embolization
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Cancer Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Tumor Resection
12.6.2 Portal Vein Embolization
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Cancer Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Tumor Resection
13.6.2 Portal Vein Embolization
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Cancer Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Metastatic Colorectal Cancer Surgery Market: Competitive Dashboard
14.2 Global Metastatic Colorectal Cancer Surgery Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Roche
14.3.3 Eli Lilly
14.3.4 Pfizer
14.3.5 Novartis
14.3.6 Amgen
14.3.7 Taiho Oncology
14.3.8 Genentech
14.3.9 EMD Serono
14.3.10 Suzhou Zelgen Biopharmaceuticals
